Fevac F5 (Inactivated) Vaccine 20's
For the immunisation of cats against feline enteritis (panleucopaenia), feline rhinotracheitis (feline herpes virus type 1), feline calicivirus, Chlamydia psittaci and feline leukaemia virus.
SKU
489
$541.50
Inactivated vaccine prepared from feline panleucopenia (feline enteritis) virus, feline rhinotracheitis virus (feline herpesvirus type 1), feline calicivirus and Chlamydophila psittaci and feline leukaemia virus (FeLV) antigen gp70. Fevac® F5 contains a water-soluble adjuvant to enhance the immune response.
Key Benefits
- Effective and well tolerated for routine use in kittens, queens and adult cats
- Being a killed vaccine, ideal for use in multi-cat environments – no risk of disease being passed to other cats in the household
- No risk of vaccine-induced respiratory disease or the chronic carrier state- considered to be the preferred type of vaccine
- Non-aluminium, water soluble adjuvant for enhanced immunity
- Convenience of vaccination against 5 diseases including Chlamydia and FeLV in a single dose
Dosage
Recommended Vaccination program for Cats
|
Vaccination |
Age |
Disease |
Vaccine |
|
1st |
6-8 weeks |
Enteritis
|
Fevac® 3 Vaccine |
|
2nd |
10-12 weeks |
Enteritis
|
Fevac® 3 Vaccine
|
|
3rd |
14-16 weeks |
Enteritis
|
Fevac® 3 Vaccine
|
|
Annual booster vaccinations |
All |
Enteritis
|
Fevac® 3 Vaccine
|
* Vaccination against Chlamydia and / or Leukaemia if deemed necessary. First dose 8 weeks of age.
Additional Information
- A correct vaccination program, particularly in a multi-cat environment (multi-cat household or boarding/breeding cattery) combined with appropriate pet care, will protect cats against the diseases listed above.
- See your veterinarian for the appropriate vaccination program with Fevac® 5.
| Refrigerated Product | Yes |
|---|---|
| Indication | Active immunisation of healthy cats 8 weeks of age or older to aid in the reduction of clinical symptoms caused by infection with feline rhinotracheitis virus, feline calicivirus, panleucopenia virus, Chlamydophila felis and feline leukaemia virus. This vaccine does not prevent infection or shedding. Based on overseas challenge data, it has been demonstrated that clinical signs of feline calicivirus infection (pyrexia, ulcers) are likely to occur in vaccinated animals following exposure to this virus. However, the severity of the fever and ulcers is likely to be reduced compared to unvaccinated animals.Vaccination does not affect the course of feline leukaemia virus (FeLV) infection in cats already infected with FeLV at the time of vaccination, implying that such cats will excrete FeLV irrespective of vaccination; consequently, these animals will constitute a hazard to susceptible cats in their environment. It is therefore recommended that cats with a significant risk of having been exposed to FeLV be tested for FeLV antigen prior to vaccination. Test-negative animals can be vaccinated, while test-positive cats should be isolated from other cats and retested within one to two months. Cats positive at the second testing should be considered as being permanently infected with FeLV and should be handled accordingly. Cats negative at second testing can be vaccinated, since in all likelihood they have overcome the FeLV infection. |
| Precautions | Vaccinate only healthy cats or kittens with normal temperatures. Animals under treatment with immunosuppressive drugs should be vaccinated with caution. Studies to support the use of the product in pregnant queens have not been conducted.Take care to avoid accidental self-injection. In the event of self-administration, seek prompt medical attention and take the package leaflet or carton with you. If possible, the application of gentle squeezing pressure with absorbent material (e.g. facial tissues) at the injection site will swab up unabsorbed vaccine. Strong squeezing of the site should be avoided.The damaged area should be thoroughly cleansed and a topical antiseptic applied. Accidental self-administration may result in local bruising, severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given. If pain persists for more than 12 hours after medical examination, seek medical advice again.First Aid If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 131 126. This material may cause a mild allergic reaction in sensitive individuals on skin contact. Avoid skin contact. If skin or hair contact occurs, remove contaminated clothing and flush skin and hair with running water. If splashed in eyes, wash out immediately with water.Disposal Dispose of empty vial by wrapping with paper and putting in garbage. Discarded syringes and needles should immediately be placed in a designated and appropriately labelled sharps container. |
| Dosage and Administration | Shake the vial well to obtain a uniform suspension of vaccine before administration. The entire contents of the vial should be used immediately after opening. The vaccine may be administered either intramuscularly (in the thigh) or subcutaneously. Each vial contains a single dose (1 mL) of vaccine. Recommended vaccination program. Fevac F5 Vaccine can be used on its own or as part of a standard vaccination program. Primary immunisation for cats aged 8 weeks and older consists of two 1 mL doses of the vaccine given at an interval of three to four weeks. It is also recommended that an annual booster with a single dose of vaccine be administered. |
| Storage | Store between 2 and 8°C. (Refrigerate. Do not freeze). Protect from light. |
| Manufacturer | Zoetis Australia Pty Ltd |
Related Products
We found other products you might like!
Write Your Own Review
